STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Avanir Pharmaceuticals, Inc. (“Avanir” or the “Company”) (Nasdaq: AVNR) relating to the proposed buyout of the Company by Otsuka Pharmaceutical Co., Ltd. (“Otsuka”). On December 2, 2014, Avanir and Otsuka announced the signing of a definitive merger a
| < Prev | Next > |
|---|
